Cargando…
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens
BACKGROUND: Tuberculosis kills more people than any other infectious disease, and new regimens are essential. The primary endpoint for confirmatory phase III trials for new regimens is a composite outcome that includes bacteriological treatment failure and relapse. Culture methodology is critical to...
Autores principales: | Phillips, Patrick P. J., Mendel, Carl M., Nunn, Andrew J., McHugh, Timothy D., Crook, Angela M., Hunt, Robert, Bateson, Anna, Gillespie, Stephen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701316/ https://www.ncbi.nlm.nih.gov/pubmed/29169355 http://dx.doi.org/10.1186/s12916-017-0955-9 |
Ejemplares similares
-
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study
por: Murphy, M. E., et al.
Publicado: (2018) -
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status
por: Tweed, Conor D., et al.
Publicado: (2019) -
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
por: Tweed, Conor Duncan, et al.
Publicado: (2018) -
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
por: Phillips, Patrick P. J., et al.
Publicado: (2016) -
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study
por: Tweed, Conor D., et al.
Publicado: (2018)